- Investing Ideas
- Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Taiwanese Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
7
Companies which are more than 50% undervalued based on analyst price target.
7 companies
Caliway Biopharmaceuticals
Market Cap: NT$161.8b
Engages in the development of drugs for aesthetic medicine and chronic inflammation.
6919
NT$104.50
7D
-0.5%
1Y
-27.9%
Lotus Pharmaceutical
Market Cap: NT$49.4b
Engages in the research and development, manufacture, and sale of generic pharmaceutical products in Taiwan, South Korea, the United States, and internationally.
1795
NT$181.50
7D
-3.5%
1Y
-9.5%
Oneness Biotech
Market Cap: NT$23.0b
Engages in the research, development, and sale of new drugs, pharmaceuticals, and health products in Taiwan.
4743
NT$46.45
7D
1.9%
1Y
-34.7%
TaiMed Biologics
Market Cap: NT$17.8b
A biotechnology company, develops, manufactures, and commercializes drugs for the treatment and prevention of infectious diseases.
4147
NT$63.90
7D
12.5%
1Y
-19.8%
Medigen Vaccine Biologics
Market Cap: NT$17.2b
A biotechnology drug company, engages in the research, development, and wholesale of vaccines and biopharmaceuticals, and medical devices in Taiwan.
6547
NT$51.60
7D
0%
1Y
28.5%
EirGenix
Market Cap: NT$15.4b
Operates as a contract development and manufacturing company in Taiwan and internationally.
6589
NT$51.30
7D
6.4%
1Y
-16.9%
Foresee Pharmaceuticals
Market Cap: NT$12.7b
Operates as biopharmaceutical company in the United States, China, and Europe.
6576
NT$79.70
7D
0.3%
1Y
4.9%